insights_auto
Why is AGIO down 3.10%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$28.76
arrow_downward
-3.10%(-0.92) 1D
US$28.76
0.00% (0.00)
bedtimeAfter hours
Closed: ኖቬም 19, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$29.93
High
US$30.35
Low
US$28.71
Mkt. cap
1.72 ቢ
Avg. vol.
1.18 ሚ
Volume
467.78 ሺ
52-wk high
US$44.07
52-wk low
US$23.02
EPS
-US$6.32
Beta
0.66
Shares outstanding
59.81 ሚ
No. of employees
540
Open
US$29.93
High
US$30.35
Low
US$28.71
Mkt. cap
1.72 ቢ
Avg. vol.
1.18 ሚ
Volume
467.78 ሺ
52-wk high
US$44.07
52-wk low
US$23.02
EPS
-US$6.32
Beta
0.66
Shares outstanding
59.81 ሚ
No. of employees
540
News stories
From web sources and news partners
The Motley Fool
·
ከ11 ሰዓቶች በፊት
Is Investing in an S&P 500 ETF Really Enough? Here's My Honest Take.
The Harvard Law School Forum on Corporate Governance
·
ከ8 ሰዓቶች በፊት
Board Practices and Composition in the Russell 3000 and S&P 500
Barron's
·
ከ8 ሰዓቶች በፊት
S&P 500 Futures Rise in Premarket Trading; Credicorp, Intercorp Finl Svcs Lead
Yahoo Finance
·
ከ23 ሰዓቶች በፊት
S&P 500 Breaks Critical Support: Is a Bigger Stock Market Crash Coming?
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc